Financials

  • Market Capitalization 319.4 M
  • Employee 106
  • Founded 2015
  • CEO N/A
  • Website www.foghorntx.com
  • Headquarter Delaware, United States
  • FIGI BBG00HFZPB88
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.58
Price to sales ratio
11

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3249
ZNTL
Zentalis Pharmaceuticals, Inc. - common stock
4.62 USD-5.33%-1.49%+19.07%+237.23%328.88 M USD
3252
PALI
Palisade Bio, Inc. - Common Stock
1.89 USD-3.57%-12.90%+9.25%+11.18%328.07 M USD
3316
IRD
Opus Genetics, Inc. - Common Stock
3.81 USD-2.81%-7.30%-7.52%+2.42%310.12 M USD
3319
EDIT
Editas Medicine, Inc. - Common Stock
3.16 USD-3.07%-13.42%+24.90%+9.72%309.38 M USD

Frequently asked questions about Foghorn Therapeutics Inc. - Common Stock

What is the Foghorn Therapeutics Inc. - Common Stock stock price today?

The current price of Foghorn Therapeutics Inc. - Common Stock (FHTX) is 5.44. Over the past 24 hours, the stock has changed by -8.57%. Follow the FHTX chart for real-time price dynamics.

What is the stock ticker of Foghorn Therapeutics Inc. - Common Stock?

Foghorn Therapeutics Inc. - Common Stock trades under the ticker FHTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Foghorn Therapeutics Inc. - Common Stock stock going up?

FHTX has changed by +7.72% over the last week, +28.30% over the last month, and +33.33% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Foghorn Therapeutics Inc. - Common Stock net income for the last quarter?

Foghorn Therapeutics Inc. - Common Stock reported net income of -19.88 M for the last quarter. The previous quarter showed -21.66 M, which means net income changed by +8.26%.

How many employees does Foghorn Therapeutics Inc. - Common Stock have?

As of the latest available data, Foghorn Therapeutics Inc. - Common Stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.

What is Foghorn Therapeutics Inc. - Common Stock EBITDA?

Foghorn Therapeutics Inc. - Common Stock EBITDA is -21.34 M, and its EBITDA margin is -653.05%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Foghorn Therapeutics Inc. - Common Stock stock?

You can buy Foghorn Therapeutics Inc. - Common Stock (FHTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Foghorn Therapeutics Inc. - Common Stock stock?

Investing in Foghorn Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FHTX chart and related analysis on metatrader.com as part of your research.

News